Keyphrases
Accelerator Mass Spectrometry
11%
Aging Lung
11%
Airspace Enlargement
11%
Aspartic Acid Racemization
11%
Carbon Residence Time
11%
Confidence Limits
11%
D-aspartate
100%
Elastic Fibers
100%
Elastin
100%
Extracellular Matrix
11%
Extracellular Matrix Protein 1 (ECM1)
11%
Gas Chromatography-mass Spectrometry
11%
Healthy Lung
22%
Human Lung
100%
Human Tissue
11%
Lung
33%
Lung Parenchyma
44%
Lung Structure
11%
Metabolic Stability
22%
Metabolically Stable
11%
New Synthesis
11%
Non-associated
11%
Normal Human
11%
Nuclear Weapons
100%
Prevalence Data
11%
Pulmonary Emphysema
11%
Specific Evaluation
11%
Structural Framework
11%
Time Elapsed
11%
Vascular Tissue
11%
Medicine and Dentistry
Accelerator Mass Spectrometry
11%
Aspartic Acid
100%
Carbon 14
100%
Disease
11%
Elastic Fiber
100%
Elastin
100%
Extracellular Matrix
22%
Gas Chromatography Mass Spectrometry
11%
Human Tissue
11%
In Vitro
11%
Injury
11%
Lung
100%
Lung Emphysema
11%
Lung Parenchyma
44%
Lung Structure
11%
Prevalence
100%
Vascular Tissue
11%
Biochemistry, Genetics and Molecular Biology
Accelerator Mass Spectrometry
11%
Aspartic Acid
100%
Elastic Fiber
100%
Elastin
100%
Gas Chromatography Mass Spectrometry
11%
Normal Human
11%
Prevalence
100%
Racemization
11%
Retention Time
11%